z-logo
open-access-imgOpen Access
Pharmaceutical and Analytical Standardization of “Medopachak Vati”
Author(s) -
Sayali Joglekar Joshi,
Sarang Deshpande
Publication year - 2020
Publication title -
journal of ayurvedic and herbal medicine
Language(s) - English
Resource type - Journals
ISSN - 2454-5023
DOI - 10.31254/jahm.2020.6212
Subject(s) - dosage form , traditional medicine , medicine , standardization , ayurvedic medicine , pharmacology , computer science , operating system
In ancient Ayurvedic classics, many formulations are there like herbal, mineral and herbomineral in origin. These formulations are effective in many diseases depending upon their qualities and properties. In this study, we are dealing with medopachak vati which is herbal preparation. In Charak Samhita, Uttarsthana, Aacharya Charak mentioned Pachak Yoga in the treatment of Vishamjwara. “Medopachak yoga” which is useful in the Treatment of Medogatjwar. Many of the Ayurvedic paractitioners prescribe Medopachak yoga in various dosage forms like kashaya (Decoction), Churna (Powder) as per their convenience. Dosage form for administration plays an important role in the reaction and delivery of particular drug on a specific system. Tablets are easy to prepare, packing, transportation and administration to patients. Hence tablet form is the most accepted dosage form amongst all. In this study, formulation of “Medopachak Yoga” is transformed to the tablet form by using modern equipments and analytical techniques. An effort is made to validate the pharmaceutical and analytical procedures to maintain the quality of product and to avoid batch to batch variation. Pharmacopeial standards are set for this Ayurvedic formulation in tablet form. All the 3 samples were prepared by this method show identical characteristics and analytical parameters do not show much significant difference. These set parameters may be used for the further pharmaceutical preparations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here